How safe should donor blood be?
We collaborated with the Netherlands blood services organization, Sanquin, to explore ethical issues in relation to blood safety.
Donor blood is screened for infectious agents to protect recipients against harmful infections. However, some screening measures may cost more than € 1,000,000 per life year gained.
There may be good reasons for aiming at very high safety levels in blood transfusion, but what costs are justified in times where public health care faces clear limits and basic health services are rationed? This question requires a better understanding of the scope of moral responsibility of blood services regarding precautions and prevention of infection via donated blood. This question is the background for several ethical substudies that aim to clarify and critically review the normative assumptions behind and arguments about current blood screening policies. Through review of arguments and concepts, taking into account the specific features of blood donation practice, this study formulates practical criteria for deciding which tests should be included in blood donor screening.
The PhD study was carried out by Koen Kramer and led by philosopher Marcel Verweij and medical microbiologist Hans Zaaijer; it is fully sponsored by Sanquin. Koen Kramer defended his PhD thesis in January 2018 at the University of Amsterdam.The thesis consists of several published articles: